New diagnostics for hypertension in diabetes and the role of chronotherapy: A new perspective

Niklas B. Rossen*, Klavs W. Hansen

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisReviewForskningpeer review

Abstract

Globally, diabetes has become one of the major causes of premature morbidity and mortality, and this is mainly attributable to the increased risk of cardiovascular (CV) disease. CV risk stratification is based on well-established risk factors including hypertension, diabetes, dyslipidaemia, smoking, age and sex. However, current assessment models are imperfect. Improved risk stratification may be achieved by the use of home and ambulatory blood pressure (BP) monitoring. Identification of new CV risk factors, which add prognostic information, may also improve risk stratification. Pulse wave velocity and central BP have been suggested as new parameters with independent prognostic ability. Moreover, treatment targets of hypertension are not met in many patients. Strategies to improve BP control include new ways of drug treatment, with chronotherapy offering a cost-free and simple approach. The present paper will review these issues with a specific focus on studies in diabetic patients.

OriginalsprogEngelsk
TidsskriftCardiovascular Endocrinology
Vol/bind5
Nummer4
Sider (fra-til)144-150
Antal sider7
ISSN2162-688X
DOI
StatusUdgivet - 1 nov. 2016

Fingeraftryk

Dyk ned i forskningsemnerne om 'New diagnostics for hypertension in diabetes and the role of chronotherapy: A new perspective'. Sammen danner de et unikt fingeraftryk.

Citationsformater